Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney Diseases

INTRODUCTION: Patients with severe kidney diseases are at risk of complications from COVID-19; however, little is known about the effectiveness of COVID-19 vaccines in children and adolescents with kidney diseases. METHODS: We investigated the immunogenicity and safety of an accelerated 3-dose prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Daniel, Chan, Eugene Yu-hin, Mu, Xiaofeng, Rosa Duque, Jaime S., Cheng, Samuel M.S., Ho, Fanny Tsz-wai, Tong, Pak-chiu, Lai, Wai-ming, Lee, Matthew H.L., Chim, Stella, Tam, Issan Y.S., Tsang, Leo C.H., Kwan, Kelvin K.H., Chung, Yuet, Wong, Howard H.W., Lee, Amos M.T., Li, Wing Yan, Sze, Summer T.K., Lam, Jennifer H.Y., Lee, Derek H.L., Chan, Sau Man, Tu, Wenwei, Peiris, Malik, Ma, Alison Lap-tak, Lau, Yu Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658278/
https://www.ncbi.nlm.nih.gov/pubmed/38025215
http://dx.doi.org/10.1016/j.ekir.2023.08.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658278/
https://www.ncbi.nlm.nih.gov/pubmed/38025215
http://dx.doi.org/10.1016/j.ekir.2023.08.014

Ejemplares similares